NasdaqGM - Delayed Quote USD
OmniAb, Inc. (OABI)
1.5200
+0.1200
+(8.57%)
At close: May 14 at 4:00:01 PM EDT
1.5500
+0.03
+(1.97%)
Pre-Market: 8:00:07 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 5 |
| Avg. Estimate | -0.15 | -0.14 | -0.6 | -0.46 |
| Low Estimate | -0.19 | -0.17 | -0.62 | -0.56 |
| High Estimate | -0.14 | -0.13 | -0.57 | -0.33 |
| Year Ago EPS | -0.13 | -0.16 | -0.61 | -0.6 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 7 |
| Avg. Estimate | 5.33M | 5.85M | 22.86M | 33.31M |
| Low Estimate | 2.24M | 3.28M | 19.7M | 25.6M |
| High Estimate | 6.81M | 6.85M | 24.9M | 45.23M |
| Year Ago Sales | 7.61M | 4.17M | 26.39M | 22.86M |
| Sales Growth (year/est) | -29.95% | 40.11% | -13.36% | 45.68% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.17 | -0.14 | -0.1 | -0.17 |
| EPS Actual | -0.13 | -0.16 | -0.12 | -0.17 |
| Difference | 0.04 | -0.02 | -0.02 | -0 |
| Surprise % | 25.00% | -17.07% | -24.13% | -2.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.15 | -0.14 | -0.6 | -0.46 |
| 7 Days Ago | -0.16 | -0.14 | -0.61 | -0.54 |
| 30 Days Ago | -0.16 | -0.14 | -0.61 | -0.54 |
| 60 Days Ago | -0.14 | -0.12 | -0.44 | -0.29 |
| 90 Days Ago | -0.14 | -0.12 | -0.44 | -0.29 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 1 | 1 | 1 |
| Up Last 30 Days | 2 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OABI | -16.67% | 10.42% | 1.91% | 23.79% |
| S&P 500 | 13.20% | 2.98% | 8.01% | 13.77% |
Upgrades & Downgrades
| Reiterates | Benchmark: Buy to Buy | 5/12/2025 |
| Maintains | RBC Capital: Outperform to Outperform | 3/27/2025 |
| Maintains | Benchmark: Buy to Buy | 3/20/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/19/2025 |
| Reiterates | Benchmark: Buy to Buy | 11/14/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/14/2024 |
Related Tickers
LGND Ligand Pharmaceuticals Incorporated
105.09
-0.51%
PVLA Palvella Therapeutics, Inc.
21.70
-6.14%
LXEO Lexeo Therapeutics, Inc.
2.6900
-4.95%
TVTX Travere Therapeutics, Inc.
21.09
+0.72%
VRCA Verrica Pharmaceuticals Inc.
0.5353
-2.67%
DSGN Design Therapeutics, Inc.
3.2150
-9.94%
ATXS Astria Therapeutics, Inc.
3.9700
+1.79%
DAWN Day One Biopharmaceuticals, Inc.
6.19
-2.21%
TERN Terns Pharmaceuticals, Inc.
2.7800
-4.14%
CNTX Context Therapeutics Inc.
0.7900
-3.66%